These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 21824920

  • 1. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
    Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC.
    Circulation; 2011 Aug 30; 124(9):1046-58. PubMed ID: 21824920
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR, Sozio SM, Chen J, Sang Y, Shafi T.
    BMC Nephrol; 2019 Apr 25; 20(1):138. PubMed ID: 31023262
    [Abstract] [Full Text] [Related]

  • 4. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J, Bundy JD, Hamm LL, Hsu CY, Lash J, Miller ER, Thomas G, Cohen DL, Weir MR, Raj DS, Chen HY, Xie D, Rao P, Wright JT, Rahman M, He J.
    Hypertension; 2019 Apr 25; 73(4):785-793. PubMed ID: 30776971
    [Abstract] [Full Text] [Related]

  • 5. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J, Malyutina S, Ryabikov A, Kontsevaya A, Kudryavtsev AV, Eggen AE, McKee M, Cook S, Hopstock LA, Schirmer H, Leon DA.
    BMC Cardiovasc Disord; 2020 Mar 13; 20(1):135. PubMed ID: 32169049
    [Abstract] [Full Text] [Related]

  • 6. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
    Bakris G, Chen C, Campbell AK, Ashton V, Haskell L, Singhal M.
    Am J Hypertens; 2024 May 15; 37(6):438-446. PubMed ID: 38436491
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER, Steigerwalt SP, Townsend RR, Weir MR, Wright JT, Rahman M, CRIC Study Investigators.
    Hypertension; 2016 Feb 15; 67(2):387-96. PubMed ID: 26711738
    [Abstract] [Full Text] [Related]

  • 9. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M, ALLHAT Collaborative Research Group.
    Hypertension; 2014 Nov 15; 64(5):1012-21. PubMed ID: 25259745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E, Bots ML, van Zuilen AD, Wetzels JF, Blankestijn PJ, MASTERPLAN Study Group.
    Hypertension; 2015 Nov 15; 66(5):998-1005. PubMed ID: 26351024
    [Abstract] [Full Text] [Related]

  • 12. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR, Booth JN, Shimbo D, Lackland DT, Oparil S, Howard G, Safford MM, Muntner P, Calhoun DA.
    J Am Soc Hypertens; 2014 Jun 15; 8(6):405-13. PubMed ID: 24952653
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E, van der Sande NGC, Bots ML, Spiering W, Voskuil M, Visseren FLJ, Blankestijn PJ.
    BMJ Open; 2017 Sep 06; 7(9):e016692. PubMed ID: 28882918
    [Abstract] [Full Text] [Related]

  • 15. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.
    Egan BM, Kai B, Wagner CS, Henderson JH, Chandler AH, Sinopoli A.
    J Clin Hypertens (Greenwich); 2016 Aug 06; 18(8):817-24. PubMed ID: 26856795
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J, Trucks-Jansen H, Schurmann C, Kotsis F, Köttgen A, Schneider MP, Eckardt KU, GCKD Investigators, Freitag DF, Eitner F, Becker MS.
    J Hum Hypertens; 2023 May 06; 37(5):345-353. PubMed ID: 35534618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
    Bakris G, Lin PP, Xu C, Chen C, Ashton V, Singhal M.
    J Clin Hypertens (Greenwich); 2024 May 06; 26(5):500-513. PubMed ID: 38523465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.